Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 19, 2022, titled “Glenmark Pharmaceuticals receives ANDA approval for Nicardipine HydrochlorideCapsules, 20 mg and 30 mg”…….
| Subscribe To Our Free Newsletter |
